Evaluating the Pharmacokinetics and Safety of Miricorilant
Evaluating the Pharmacokinetics and Safety of Miricorilant
Recruiting · NCT07553663 · Registry updated 2026-05-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Pharmacokinetics and Safety of Miricorilant | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 1 | 2026-05-26 | NCT07553663 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Corcept Therapeutics | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Site# 433 | San Antonio | United States | 1 |